NICE recommends pixantrone for NHLJanuary 7, 2014Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
FDA approves ibrutinib for previously treated MCLNovember 14, 2013Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Company suspends enrollment in drug trialsFebruary 21, 2013Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
CD19-redirected T cells induce remission in CLL patientsAugust 10, 2011Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
FDA warns of possible link between breast implants and ALCLJanuary 27, 2011Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Denileukin diftitox has significant, durable responses in CTCLApril 1, 2010Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Fostamatinib successfully targets the B-cell receptorDecember 13, 2009Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Ofatumumab receives accelerated approval from FDAOctober 27, 2009Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Potential cause of R-CHOP failure ruled outMarch 11, 2009Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
